ArticleContemporary clinical trials communications2022

Innovation in the treatment of persistent pain in adults with Neurofibromatosis Type 1 (NF1): Implementation of the iCanCope mobile application.

Frank D Buono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.